ESTRO 2024 - Abstract Book

S4629

Physics - Optimisation, algorithms and applications for ion beam treatment planning

ESTR0 2024

Conclusion:

We developed an experimental and MC platform with a modified anthropomorphic phantom that could be used to quantify the eventual benefit of PBS for a wide range of indications.

Keywords: cancer in pregnancy, out-of-field dosimetry, fetus

References:

1. Haas JF. Pregnancy in association with a newly diagnosed cancer: a population-based epidemiologic assessment. Int J Cancer. 1984;34(2):229–35. 2. Eibye S, Kjaer SK, Mellemkjaer L. Incidence of pregnancy-associated cancer in Denmark, 1977-2006. Obstet Gynecol. 2013;122(3):608–17. 3. Stensheim H, Moller B, van Dijk T, Fossa SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol. 2009;27(1):45–51. 4 Donegan WL. Cancer and pregnancy. CA Cancer J Clin. 1983;33(4):194–214. doi: 10.3322/canjclin.33.4.194. 5. Peccatori F.A., Azim H.A., Orecchia R., Hoekstra H.J., Pavlidis N., Kesic V., Pentheroudakis G. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2013;24(Suppl. 6):vi160–vi170. doi: 10.1093/annonc/mdt199. 6. Silverstein J., Post A.L., Chien A.J., Olin R., Tsai K.K., Ngo Z. Multidisciplinary management of cancer during pregnancy. JCO Oncol. Pract. 2020;16:545–557. doi: 10.1200/OP.20.00077. 7. De Haan, J., Verheecke, M., Van Calsteren, K., Van Calster, B., Shmakov, R. G., Mhallem Gziri, M., … Amant, F. (2018). Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. The Lancet Oncology, 19(3), 337–346. doi:10.1016/s1470-2045(18)30059-7 8. Amant, F., Loibl, S., Neven, P., & Van Calsteren, K. (2012). Breast cancer in pregnancy. The Lancet, 379(9815), 570– 579. doi:10.1016/s0140-6736(11)61092-1 9. W. J. Schull, Effects of Atomic Radiation: A Half Century of Studies from Hiroshima and Nagasaki Wiley-Liss, New York, 1995. 10. Stovall M, American Institute of Physics, American Association of Physicists in Medicine. Fetus dose from radiotherapy with photon beams. AAPM Rep. 1995;50:63-82. 11. P. Fattibene et al., “Prenatal exposure to ionizing radiation: Sources, effects, and regulatory aspects,” Acta Paediatr. 88, 693–702 1999. 12. Kal, H. B., & Struikmans, H. (2005). Radiotherapy during pregnancy: fact and fiction. The lancet oncology, 6(5), 328-333. 13. Schull, W. J., & Otake, M. (1987). Effect on intelligence of prenatal exposure to ionizing radiation (No. RERF-TR--7 86). Radiation Effects Research Foundation. 14. Otake, M. (1996). Threshold for radiation-related severe mental retardation in prenatally exposed A-bomb survivors: a re-analysis. International journal of radiation biology, 70(6), 755-763. 15. Schull, W. J., Otake, M., & Yoshimaru, H. (1988). Effect on intelligence test score of prenatal exposure to ionizing radiation in Hiroshima and Nagasaki (No. RERF-TR--3-88). Radiation Effects Research Foundation. 16. Doll, R., & Wakeford, R. (1997). Risk of childhood cancer from Fetus irradiation. The British journal of radiology, 70(830), 130-139. 17. ICRP. Biological effects after prenatal irradiation (embryo and fetus). ICRP publication 90. Ann ICRP. 2003;33(1– 2).